Vanguard Group
ASPX

Vanguard Group’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Vanguard Group’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-882,423
Closed -$88.5M – 4238
2015
Q1 		$88.5M Buy
882,423
+450,085
+104% +$30M 0.01% 1585
2014
Q4 		$22.7M Buy
432,338
+69,507
+19% +$2.04M ﹤0.01% 2187
2014
Q3 		$9.31M Buy
362,831
+219,310
+153% +$4.67M ﹤0.01% 2532
2014
Q2 		$3.2M Buy
143,521
+106,525
+288% +$2.33M ﹤0.01% 3047
2014
Q1 		$1.14M Buy
+36,996
New +$994K ﹤0.01% 3414

Vanguard Group's ASPX Position: Q2 2015 in Review

Vanguard Group sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 882,423 shares — an estimated $88.5M sold.

Vanguard Group first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $88.5M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Vanguard Group reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Vanguard Group sold 882,423 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $88.5M.
  • Vanguard Group first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Vanguard Group's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $88.5M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Vanguard Group's 13F filing for Q2 2015, filed 13 Aug 2015.